Fieldview Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$769K Sell
17,626
-680
-4% -$31.5K 0.22% 144
2026
Q2
$781K Buy
18,306
+3,491
+24% +$190K 0.22% 131
2026
Q1
$930K Buy
+14,815
New +$1.19M 0.27% 116
2025
Q4
– Sell
-54,715
Closed -$5.34M – 495
2025
Q3
$5.34M Buy
+54,715
New +$5.67M 0.87% 11

Other funds holding BSX

Fieldview Capital Management's BSX Position: Q3 2026 in Review

Fieldview Capital Management reduced its Boston Scientific (BSX) stake by 3.7% in Q3 2026, selling an estimated $31.5K and leaving 17,626 shares worth $769K. The position accounts for 0.22% of the portfolio, ranked #144.

Fieldview Capital Management first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.34M in Q3 2025. 1,504 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Fieldview Capital Management held 17,626 shares of Boston Scientific worth $769K as of Q3 2026.
  • Fieldview Capital Management sold 680 Boston Scientific shares in Q3 2026, an estimated $31.5K.
  • Boston Scientific made up 0.22% of Fieldview Capital Management's portfolio in Q3 2026, its #144 holding.
  • Fieldview Capital Management first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Fieldview Capital Management's Boston Scientific position peaked at $5.34M in Q3 2025.
  • 1,504 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Fieldview Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.